PERCEPTIVE ADVISORS LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1224962
NEW YORK, NY
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$681,627,752
+$25,653,423 QoQ
Shares Held
2,035,986
0.0% QoQ
Ownership
7.29%
of shares outstanding
% of Portfolio
10.99%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Dec 31, 2024CallValue
$38,480,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. PRAX ranks #1 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in PRAX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $681,627,752 | 2,035,986 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $655,974,329 | 2,035,986 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $588,296,913 | 1,995,986 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $82,921,362 | 1,564,554 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,660,328 | 752,921 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,146,455 | 980,894 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $38,480,000 | 500,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $102,336,405 | 1,329,735 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $66,978,573 | 1,164,035 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,029,512 | 750,230 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $50,133,360 | 821,589 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||